LUPIN

LUPIN
LUPIN was Incorporated in 1972, Lupin Limited (“Lupin” or the “Company”) is a

pharmaceutical company producing a wide range of quality affordable generic and branded
formulations and Active Pharmaceutical Ingredients (APIs). The Company was formerly
known as Lupin Chemicals Ltd. and changed its name to Lupin Limited in 2001 as a result of
its amalgamation with Lupin Laboratories Ltd.
Lupin Limited is a multinational pharmaceutical company based in Mumbai. It is the 12th-
largest company by market capitalization; and the eighth-largest generic pharmaceutical
company by revenue globally. The company's key focus areas include paediatrics,
cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.
History and evolution.

Lupin was founded in 1968 by Desh Bandhu Gupta, who was a professor of chemistry at
BITS-Pilani, Rajasthan. Gupta moved to Mumbai in the 60s to work on his business
enterprise for which initially he had initially borrowed Rs 5000 from his wife to fund his
venture. Subsequent funding of 800000 from Central Bank of India, the company was able
to start their manufacturing facility for producing folic acid and iron tablets for Government
of India mother and child health program. Later Lupin started manufacturing anti TB drugs
which at one point formed 36% of the company sales and was considered as the largest TB
drugs manufacturer in the world.
After success with Lupin, in 1988 Gupta founded the group's CSR arm, the Lupin Human
Welfare & Research Foundation (LHWRF). This initiative was dedicated to sustainable rural
development with the aim to uplift families living below the poverty line. This vision of rural
development focuses on holistic development programs that systematically create
opportunities and infrastructure, while empowering people in rural areas, to bring about a
socio-economic change and ensure the inclusion of rural communities in the nation’s
economic progress. Nationally, the Lupin Foundation impacts the lives of 2.8 million people
living in about 3,500 villages spread across 9 states – Rajasthan, Maharashtra, Madhya
Pradesh, Goa, Uttarakhand, Gujarat, Jammu, Andhra Pradesh, and Sikkim.
Desh Bandhu Gupta (8 February 1938 – 26 June 2017) was an Indian billionaire,
philanthropist, entrepreneur and the founder of Lupin Limited, a multinational
pharmaceutical company. Gupta started his career as an associate professor at the Birla
Institute of Technology and Science, Pilani, Rajasthan. He quit teaching and decided to be an
entrepreneur as he was "not able to implement ideas into practice". He moved to Mumbai
and worked in a small British pharmaceutical manufacturing company.
Research and Development.
Lupin's research program covers the entire pharma product chain. The company's R&D
program is headquartered in the Lupin Research Park located near Pune that houses over
1400 scientists. Lupin's R&D covers:
 Generics Research
 Process Research
 Pharmaceutical Research
 Advanced Drug Delivery Systems (ADDS) Research
 Intellectual Property Management
 Novel Drug Discovery and Development (NDDD)
 Biotechnology Research
Business
Lupin's businesses encompass the entire pharmaceutical value chain, ranging from branded
and generic formulations, APIs, advanced drug delivery systems to biotechnology. The
company's drugs reach 70 countries with a footprint that covers advanced markets such as
USA, Europe, Japan, Australia as well as emerging markets including India, the Philippines
and South Africa to name a few. 67% of the overall business of the Company comes from
International Markets. Lupin’s global formulations business constitutes close to 84% of its
overall business mix, and in terms of geographies, USA is its largest market outside India.
The Company operates a globally integrated network of 11 manufacturing facilities spread
across India and Japan.
INTERNATIONAL PRESENCE
USA -CVS and Pediatric segments.
JAPAN-Neurology, Cardiovascular, Gastroenterology,Respiratory segments
SOUTH AFRICA - Cardiovascular and Neurology segment
AUSTRALIA- Goanna, Pain segments.
PHILIPPINES - Women's Health, Pediatrics, Gastro-Intestinal and Diabetes
GERMANY
NETHERLAND
BRAZIL- ophthalmic products
RUSSIA - ophthalmic products

LUPIN

Uploaded by

Copyright:

Available Formats

LUPIN

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

LUPIN

Uploaded by

Copyright:

Available Formats

LUPIN

LUPIN was Incorporated in 1972, Lupin Limited (“Lupin” or the “Company”) is a

History and evolution.

USA -CVS and Pediatric segments.

JAPAN-Neurology, Cardiovascular, Gastroenterology,Respiratory segments

SOUTH AFRICA - Cardiovascular and Neurology segment

AUSTRALIA- Goanna, Pain segments.

PHILIPPINES - Women's Health, Pediatrics, Gastro-Intestinal and Diabetes

BRAZIL- ophthalmic products

RUSSIA - ophthalmic products

You might also like